Immunocytochemical analysis of D-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons

GLIA

Volumn 53, Issue 4, 2006, Pages 401-411

  Williams, Susan M ^a,b,c   Diaz, Claudia M ^a,b   Macnab, Lauren T ^a,b,c   Sullivan, Robert K P ^a,b,c   Pow, David V ^a,b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HMRI ^*  (Australia)

^c Neuroscience Institute of Schizophrenia and Allied Disorders NISAD   (Australia)

Author keywords

Astrocyte; Glycine; Microglia; NMDA; Vesicle

Indexed keywords

ANTIBODY; ANTIGEN; GLUTARALDEHYDE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SERINE;

ANATOMY; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BINDING SITE; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN STEM; CELL COMPARTMENTALIZATION; CELL SUBPOPULATION; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FOREBRAIN; GLIA CELL; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MAMMAL; NEUROMODULATION; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TISSUE FIXATION;

AGING; ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; FIXATIVES; FORMALDEHYDE; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLYCINE; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; NEUROGLIA; NEURONS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; SERINE; SYNAPTIC VESICLES; TISSUE FIXATION;

EID: 33644560634     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20300     Document Type: Article

References (49)

1. Abdipranoto A, Liu GJ, Werry EL, Bennett MR. 2003. Mechanisms of secretion of ATP from cortical astrocytes triggered by uridine triphosphate. NeuroReport 14:2177-21781.
2. Anlauf E, Derouiche A. 2005. Astrocytic exocytosis vesicles and glutamate: a high-resolution immunofluorescence study. Glia 49:96-106.
3. Burgoyne RD. 1990. Secretory vesicle-associated proteins and their role in exocytosis Annu Rev Physiol 52:647-659.
4. Coyle JT, Tsai G, Goff DC, 2002. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord 1:183-189.
5. Hashimoto A. 2002. Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat. Brain Res 955:214-220.
6. Hashimoto A, Chiba S. 2004. Effect of systemic administration of D-serine on the levels of D- and L-serine in several brain areas and periphery of rat. Eur J Pharmacol 495:153-158.
7. Hashimoto A, Nishikawa T, Oka T, Takahashi K, Hayashi T. 1992. Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J Chromatogr 582:41-48.
8. Hashimoto A, Nishikawa T, Konno R, Niwa A, Yasumura Y, Oka T, Takahashi K. 1993a. Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase. Neurosci Lett 152:33-36.
9. Hashimoto A, Nishikawa T, Oka T, Takahashi K. 1993b. Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging. J Neurochem 60:783-786.
10. Hashimoto A, Oka T, Nishikawa T. 1995. Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience 66:635-643.
11. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstrom LH, Iyo M. 2005. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 29:767-769.
12. Heresco-Levy U, Javitt DC. 2004. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophr Res 66:89-96.
13. Heresco-Levy U, Javitt DC, Ermilov M, Silipo G, Shimoni J. 1998. Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia. Int J Neuropsychopharmacol 1:131-135.
14. Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M. 2005. D-Serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 57:577-585.
15. Johnson JW, Ascher P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531.
16. Kim PM, Aizawa H, Kim PS, Huang AS, Wickramasinghe SR, Kashani AH, Barrow RK, Huganir RL, Ghosh A, Snyder SH. 2005. Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proc Natl Acad Sci USA 102:2105-2110.
17. Kleckner NW, Dingledine R. 1988. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241:835-837.
18. Mayer ML, Vyklicky L Jr, Clements J. 1989. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338:425-427.
19. Meldrum BS, Evans MC, Swan JH, Simon RP. 1987. Protection against hypoxic/ischaemic brain damage with excitatory amino acid antagonists. Med Biol 65:153-157.
20. Montana V, Ni Y, Sunjara V, Hua X, Parpura V. 2004. Vesicular glutamate transporter-dependent glutamate release from astrocytes. J Neurosci 24:2633-2642.
21. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD, Rogawski MA, Snyder SH. 2000. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 97:4926-4931.
22. Mothet JP, Pollegioni L, Ouanounou G, Martineau M, Fossier P, Baux G. 2005. Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine. Proc Natl Acad Sci USA 102:5606-5611.
23. Nagata Y, Masui R, Akino T. 1992. The presence of free D-serine, D-alanine and D-proline in human plasma. Experientia 48:986-988.
24. Pow DV, Clark A. 1990. Localisation of peptide hormones by light and electron microscopy. In: Hutton JC, Siddle K, editors. Peptide hormone secretion. Practical handbook series. IRL Press, Oxford, UK. p 189-210.
25. Pow DV, Crook DK. 1993. Extremely high titre polyclonal antisera against small neurotransmitter molecules: rapid production, characterisation and use in light- and electron-microscopic immunocytochemistry. J Neurosci Methods 48:51-63.
26. Pow DV, Perry VH, Morris JF, Gordon S. 1989. Microglia in the neurohypophysis associate with and endocytose terminal portions of neurosecretory neurons. Neuroscience 33:567-578.
27. Pow DV, Wright LL, Vaney DI. 1995. The immunocytochemical detection of amino-acid neurotransmitters in paraformaldehyde-fixed tissues. J Neurosci Methods 56:115-123.
28. Pow DV, Sullivan R, Scott H. 2003. Antibody production and immunocytochemical localization of amino acid transporters. Methods Mol Biol 227:213-244.
29. Reye P, Sullivan R, Fletcher EL, Pow DV. 2002a. Distribution of two splice variants of the glutamate transporter GLT1 in the retinas of humans, monkeys, rabbits, rats, cats, and chickens. J Comp Neurol 445:1-12.
30. Reye P, Sullivan R, Pow DV. 2002b. Distribution of two splice variants of the glutamate transporter GLT-1 in the developing rat retina. J Comp Neurol 447:323-330.
31. Reye P, Sullivan R, Scott H, Pow DV. 2002c. Distribution of two splice variants of the glutamate transporter GLT-1 in rat brain and pituitary. Glia 38:246-255.
32. Schell MJ. 2004. The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective. Philos Trans R Soc Lond B Biol Sci 359:943-964.
33. Schell MJ, Molliver ME, Snyder SH. 1995. D-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92:3948-3952.
34. Schell MJ, Brady RO Jr, Molliver ME, Snyder SH. 1997. D-Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci 17:1604-1615.
35. Scott HL, Pow DV, Tannenberg AE, Dodd PR. 2002. Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J Neurosci 22:RC206.
36. Snyder SH, Kim PM. 2000. D-amino acids as putative neurotransmitters: focus on D-serine. Neurochem Res 25:553-560.
37. Sullivan R, Rauen T, Fischer F, Wiessner M, Grewer C, Bicho A, Pow DV. 2004. Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis. Glia 45:155-69.
38. Tetsuka K, Takanaga H, Ohtsuki S, Hosoya K, Terasaki T. 2003. The 1-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier. J Neurochem 87:891-901.
39. Tsai G, Yang P, Chung LC, Lange N, Coyle JT. 1998. D-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44:1081-1089.
40. Virgo L, de Belleroche J. 1995. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 676:196-204.
41. Wang LZ, Zhu XZ. 2003. Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development. Acta Pharmacol Sin 24:965-974.
42. Wilhelm A, Volknandt W, Langer D, Nolte C, Kettenmann H, Zimmermann H. 2004. Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ. Neurosci Res 48:249-257.
43. Williams SM, Sullivan RK, Scott HL, Finkelstein DI, Colditz PB, Lingwood BE, Dodd PR, Pow DV. 2005. Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia 49:520-541.
44. Wilson JM, Khabazian I, Pow DV, Craig UK, Shaw CA. 2003. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC. Neuromol Med 3:105-118.
45. Wolosker H, Blackshaw S, Snyder SH. 1999a. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci USA 96:13409-13414.
46. Wolosker H, Sheth KN, Takahashi M, Mothet JP, Brady RO Jr, Ferris CD, Snyder SH. 1999b. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci USA 96:721-725.
47. Wu SZ, Bodies AM, Porter MM, Griffin WS, Basile AS, Barger SW. 2004a. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J Neuroinflammation 1:2.
48. Wu S, Barger SW, Sims TJ. 2004b. Schwann cell and epineural fibroblast expression of serine racemase. Brain Res 1020:161-166.
49. Yasuda E, Ma N, Semba R. 2001. Immunohistochemical demonstration of L-serine distribution in the rat brain. NeuroReport 12:1027-1030.